PhenomeX Inc CELL

NAS: CELL | ISIN: US0843101017   29/09/2023
0,998 USD (+0,31%)
(+0,31%)   29/09/2023

27 september 2023 · PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic Platform · Persbericht

21 september 2023 · PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows · Persbericht

20 september 2023 · PhenomeX to Participate in Upcoming Cell Biology Conferences · Persbericht

15 september 2023 · PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics · Persbericht

5 september 2023 · PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker · Persbericht

14 augustus 2023 · PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update · Persbericht

9 augustus 2023 · PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023 · Persbericht

7 augustus 2023 · PhenomeX Announces Lifting of the Stay in AbCellera Patent Infringement Case · Persbericht

13 juni 2023 · PhenomeX's Beacon® Technology Enables Early Identification of Potent Omicron-Neutralizing Antibodies · Persbericht

5 juni 2023 · PhenomeX Launches Beacon Quest™ Optofluidic System with Opto® T Cell Profiling Workflows · Persbericht

15 mei 2023 · PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows · Persbericht

11 mei 2023 · PhenomeX Reports First Quarter 2023 Financial Results · Persbericht

11 mei 2023 · PhenomeX To Participate in 19th Annual PEGS Boston Conference & Expo · Persbericht

27 april 2023 · PhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023 · Persbericht

17 april 2023 · PhenomeX Launches the Opto® T Cell Profiling Workflow · Persbericht

10 april 2023 · PhenomeX Appoints Peter Silvester to PhenomeX Board of Directors · Persbericht

7 april 2023 · PhenomeX to Participate in American Association of Cancer Research Annual Meeting 2023 · Persbericht

Mijn selecties